Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Glioblastoma cell supermeres

ABSTRACT: Glioblastoma cell supermeres

PROVIDER: PRJNA1136530 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR29848821.fastq.gz	Fastqsanger.gz
	SRR29848822.fastq.gz	Fastqsanger.gz
	SRR29848823.fastq.gz	Fastqsanger.gz
	SRR29848824.fastq.gz	Fastqsanger.gz
	SRR29848825.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 17

Similar Datasets

Glioblastoma cell supermeres

Project description:To identify small RNAs coming out of glioblastoma cells in supermeres and other carriers

2024-07-31 | GSE272370 | GEO

Colorectal cancer cell supermeres

Project description:Colorectal cancer cell supermeres

| PRJNA1136961 | ENA

Colorectal cancer cell supermeres

Project description:To identify the best method for isolating supermeres and their small RNA cargo from colorectal cancer cells

2024-07-31 | GSE272487 | GEO

Colorectal cancer cell supermeres isolation methods

Project description:To identify the best method for isolating supermeres and their small RNA cargo from colorectal cancer cells

2024-07-31 | GSE272488 | GEO

Colorectal cancer cell supermeres isolation methods

Project description:Colorectal cancer cell supermeres isolation methods

| PRJNA1136963 | ENA

Supermeres, a new functional extracellular nanoparticle replete with disease biomarkers and therapeutic targets

Project description:RNA-Seq of cellular and extracellular samples from DiFi cells. The distribution of extracellular RNA among cells, sEV pellet, exomeres and supermeres is distinct.

2021-10-12 | GSE168416 | GEO

Supermeres in breast and pancreatic cancer cells

Project description:Extracellular vesicles, including exosomes, and exomere nanoparticles, are under intense investigation for cargo that may serve as clinical biomarkers or therapeutic targets. Here, we report discovery of a new extracellular nanoparticle, termed supermeres. We performed LC/MS-MS proteomics analyses on gradient-purified sEVs, NVs, exomeres and supermeres. The proteomic profile of supermeres is clearly distinct from that of sEVs, NVs and exomeres. This study identifies a new functional nanoparticle replete with potential circulating biomarkers and therapeutic targets that can be exploited for clinical benefit in a host of diseases.

2021-12-01 | PXD027258 | Pride

Proteome of DiFi and CC-CR supermeres purified by FPLC with or without additional affinity purification for TGFBi

Project description:The cell seretome is diverse and contains extracellular secreted vesicles (EVs) as well as non-vesicular extracellular nanoparticles (NVEPs) called exomeres and supermeres, all of which carry different kinds of cell signaling cargos. One supermere enriched cargo is transforming growth factor beta induced (TGFBi) protein. We have created TGFBi-neon green-His tagged expressing cell lines in the microsatellite stable (MSS) colorectal cancer cell line DiFi and another one in CC-CR cells with microsatellite instability (MSI). We have developed a fast protein liquid chromatography (FPLC) method for isolating EVs, exomeres and supermeres from biofluids. We used either FPLC or FPLC and then nickel columns that bind His tags to isolate supermeres from DiFi or CC-CR cells. We utilized a proteomics approach acquiring LC-MS/MS data to compare FPLC to FPLC and His tagged TGFBi-containing purified supermeres from DiFi and CC-CR cells. This was done using hollow fiber 3D bioreactor production of conditioned media from these cell lines.

2025-09-11 | PXD066888 | Pride

Supermeres, a new functional extracellular nanoparticle replete with disease biomarkers and therapeutic target

Project description:Extracellular vesicles, including exosomes, and exomere nanoparticles, are under intense investigation for cargo that may serve as clinical biomarkers or therapeutic targets. Here, we report discovery of a new extracellular nanoparticle, termed supermeres. We performed LC/MS-MS proteomics analyses on gradient-purified sEVs, NVs, exomeres and supermeres. The proteomic profile of supermeres is clearly distinct from that of sEVs, NVs and exomeres This study identifies a new functional nanoparticle replete with potential circulating biomarkers and therapeutic targets that can be exploited for clinical benefit in a host of diseases.

2021-11-02 | PXD025213 | Pride

Proteome of DiFi EVs, exomeres and supermeres purified by ultracentrifugation and FPLC

Project description:The cell seretome is diverse and contains extracellular secreted vesicles (EVs) as well as non-vesicular extracellular nanoparticles (NVEPs) called exomeres and supermeres, all of which carry different kinds of cell signaling cargos. We have developed new techniques to purify exomeres and supermeres by ultracentrifugation (UC) and by fast protein liquid chromatography (FPLC) from cell conditioned media and from blood plasma. We utilized a proteomics approach to compare UC and FPLC methods with standard UC and density gradient methods of isolating EVs and new methods of isolating NVEPs. We acquired LC-MS/MS data from conditioned media using standard 2D plastic and hollow fiber 3D bioreactor production from a CRC cell line, DiFi, using all these methods and growth culture conditions.

2025-09-11 | PXD066872 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data